Publications by authors named "Jonathan Kitonsa"

Claim this Profile
E
Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA).
Victoria Babirye Tumusiime, Eugene Ruzagira, Claire Norcross, Ingrid Eshun-Wilsonova, Jonathan Kitonsa

Wellcome Open Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Resilience amidst challenges": Healthcare users' experiences of access and utilisation of primary healthcare services during the COVID-19 pandemic in southwestern Uganda.
Rachel Kawuma, Joseph Katongole, Abdmagidu Menya, Winnie Eoju, Jonathan Kitonsa

PLOS Glob Public Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial.
Ahmad Mourad, Gregory A Grandits, Lianne K Siegel, Nicole Engen, Christina Barkauskas, Jonathan Kitonsa

Clin Microbiol Infect· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.
Jonathan Kitonsa, Jennifer Serwanga, Hannah M Cheeseman, Andrew Abaasa, Jane Frances Lunkuse

Vaccines (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial).
Sofía Sábato, Susana Benet, Angela J Rogers, Thomas A Murray, Melissa Skeans, Jonathan Kitonsa

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials.
Paola Del Carmen Guerra-de-Blas, Rubria Marines-Price, Olga Milman, Danae Deal, Jonathan Marchand, Jonathan Kitonsa

J Clin Transl Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda.
Jonathan Kitonsa, Sheila Kansiime, Sylvia Kusemererwa, Martin Onyango, Berna Nayiga

Glob Health Action· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.
Jonathan Kitonsa, Onesmus Kamacooko, Eugene Ruzagira, Florence Nambaziira, Andrew Abaasa

Hum Vaccin Immunother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immediate treatment outcomes and cost estimate for managing clinical measles in children admitted at Mulago Hospital: A retrospective cohort study.
Barbara Namugga, Ombeva Malande, Jonathan Kitonsa, Leonard Manirakiza, Cecily Banura

PLOS Glob Public Health· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study.
Bolarinde J Lawal, Katherine E Gallagher, Jonathan Kitonsa, Daniel Tindanbil, Kambale Kasonia

Int J Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.
Thomas A Rasmussen, Sunil K Ahuja, Locadiah Kuwanda, Michael J Vjecha, Fleur Hudson, Jonathan Kitonsa

Clin Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Acceptability Among Healthcare Facility Workers in Sierra Leone, the Democratic Republic of Congo and Uganda: A Multi-Centre Cross-Sectional Survey.
Hilary S Whitworth, Jonathan Kitonsa, Kambale Kasonia, Daniel Tindanbil, Paddy Kafeero

Int J Public Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO).
Eleftherios Mylonakis, Joseph Lutaakome, Mamta K Jain, Angela J Rogers, José Moltó, Jonathan Kitonsa

Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda.
Anita Kabarambi, Sheila Kansiime, Sylvia Kusemererwa, Jonathan Kitonsa, Pontiano Kaleebu

Int J Environ Res Public Health· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda.
Sylvia Kusemererwa, Sheila Kansiime, Gertrude Mutonyi, Aeron Namirembe, Safina Katana, Jonathan Kitonsa

Medicine (Baltimore)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda.
Jonathan Kitonsa, Onesmus Kamacooko, Ubaldo Mushabe Bahemuka, Freddie Kibengo, Ayoub Kakande

PLoS One· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge, Attitudes, and Practices Regarding COVID-19 among Healthcare Workers in Uganda: A Cross-Sectional Survey.
Onesmus Kamacooko, Jonathan Kitonsa, Ubaldo M Bahemuka, Freddie M Kibengo, Anne Wajja

Int J Environ Res Public Health· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis.
Jonathan Kitonsa, Julius Kiwanuka, Zacchaeus Anywaine, Sheila Kansiime, Kenneth Katumba

PLoS Negl Trop Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda.
Jonathan Kitonsa, Abu-Baker Ggayi, Zacchaeus Anywaine, Eva Kisaakye, Laura Nsangi

Glob Health Action· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.
Jonathan Kitonsa, Rebecca Nsubuga, Yunia Mayanja, Julius Kiwanuka, Yofesi Nikweri

PLoS Negl Trop Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Julius Kiwanuka, Jacinta Mukulu Waila, Methuselah Muhindo Kahungu, Jonathan Kitonsa, Noah Kiwanuka

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda.
Jonathan Kitonsa, Yunia Mayanja, Emmanuel Aling, Julius Kiwanuka, Juliana Namutundu

PLoS One· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis